BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14516923)

  • 1. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens.
    Al-Sherbiny M; Osman A; Barakat R; El Morshedy H; Bergquist R; Olds R
    Acta Trop; 2003 Oct; 88(2):117-30. PubMed ID: 14516923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and humoral immune responses to recombinant Smp17.7 Schistosoma mansoni antigen.
    Al-Sherbiny MM; Galal IF; Karim AM; Ashour AA; Saad AH
    J Egypt Soc Parasitol; 2003 Dec; 33(3):925-46. PubMed ID: 14708863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm.
    Webster M; Correa-Oliveira R; Gazzinelli G; Viana IR; Fraga LA; Silveira AM; Dunne DW
    Am J Trop Med Hyg; 1997 Oct; 57(4):487-94. PubMed ID: 9347969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immune responses to Schistosoma mansoni vaccine candidate antigens.
    Ribeiro de Jesus A; Araújo I; Bacellar O; Magalhães A; Pearce E; Harn D; Strand M; Carvalho EM
    Infect Immun; 2000 May; 68(5):2797-803. PubMed ID: 10768975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.
    Chalmers IW; Fitzsimmons CM; Brown M; Pierrot C; Jones FM; Wawrzyniak JM; Fernandez-Fuentes N; Tukahebwa EM; Dunne DW; Khalife J; Hoffmann KF
    PLoS Negl Trop Dis; 2015; 9(7):e0003920. PubMed ID: 26147973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells.
    Fonseca CT; Cunha-Neto E; Kalil J; Jesus AR; Correa-Oliveira R; Carvalho EM; Oliveira SC
    Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):63-6. PubMed ID: 15486637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
    Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
    Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of immunodiagnostic assays: detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings.
    Al-Sherbiny MM; Osman AM; Hancock K; Deelder AM; Tsang VC
    Am J Trop Med Hyg; 1999 Jun; 60(6):960-6. PubMed ID: 10403328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of Schistosoma mansoni.
    Richter D; Reynolds SR; Harn DA
    J Immunol; 1993 Jul; 151(1):256-65. PubMed ID: 8326127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid.
    Riner DK; Ndombi EM; Carter JM; Omondi A; Kittur N; Kavere E; Korir HK; Flaherty B; Karanja D; Colley DG
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005180. PubMed ID: 27926921
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community.
    Naus CW; Booth M; Jones FM; Kemijumbi J; Vennervald BJ; Kariuki CH; Ouma JH; Kabatereine NB; Dunne DW
    Trop Med Int Health; 2003 Jun; 8(6):561-8. PubMed ID: 12791062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis.
    El Ridi R; Mahrous A; Afifi A; Montash M; Velek J; Jezek J
    Scand J Immunol; 2001 Nov; 54(5):477-85. PubMed ID: 11696199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine.
    Petzke MM; Suri PK; Bungiro R; Goldberg M; Taylor SF; Ranji S; Taylor H; McCray JW; Knopf PM
    Parasite Immunol; 2000 Aug; 22(8):381-95. PubMed ID: 10972845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH.
    Argiro LL; Kohlstädt SS; Henri SS; Dessein HH; Matabiau VV; Paris PP; Bourgois AA; Dessein AJ
    Vaccine; 2000 Apr; 18(19):2039-48. PubMed ID: 10706967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice.
    Yang W; Jackson DC; Zeng Q; McManus DP
    Vaccine; 2000 Aug; 19(1):103-13. PubMed ID: 10924792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a major T cell immunogen in the anti-schistosome response of adult residents in an area endemic for Schistosoma mansoni.
    Couissinier-Paris P; Bourgois A; Dessein H; Bacellar O; Rodrigues V; Kohlstädt S; Buonavista N; Pène J; Dessein AJ
    Eur J Immunol; 1995 Apr; 25(4):903-10. PubMed ID: 7737292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic significance of Schistosoma mansoni proteins Sm31 and Sm32 in human schistosomiasis in an endemic area in Egypt.
    El-Sayed LH; Ghoneim H; Demian SR; El-Sayed MH; Tawfik NM; Sakr I; Abou-Basha LM; Renganathan E; Klinkert MQ; Abou-Rawash N
    Trop Med Int Health; 1998 Sep; 3(9):721-7. PubMed ID: 9754667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.